Inese Čakstiņa

595 citations
16 papers · 489 indexed · h-index 9
Topics
Mesenchymal stem cell research (5 papers)Cancer Cells and Metastasis (3 papers)RNA Research and Splicing (3 papers)

In The Last Decade

Inese Čakstiņa

16 papers receiving 487 citations

Peers

Inese Čakstiņa
Comparison fields: 5 of 80
  • Genetics 252
  • Molecular Biology 222
  • Surgery 173
  • Biomedical Engineering 83
  • Biomaterials 57
Replace Aristea Batsali with:
Aristea Batsali Greece
I. V. Arutyunyan Russia
Alba Murgia Italy
Erik Pittermann Germany
Ross Fitzsimmons Canada
Jina Bhattacharyya India
Gangzheng Hu China
Sangeetha Kandoi United States
Owen Marecic United States
Inese Čakstiņa relative to Aristea Batsali Greece Aristea Batsali's profile →
Citations per field
00.5×1.5×
Aristea Batsali · 1×
Citations per year

Countries citing papers authored by Inese Čakstiņa

Since Specialization
Citations

This map shows the geographic impact of Inese Čakstiņa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inese Čakstiņa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inese Čakstiņa more than expected).

Fields of papers citing papers by Inese Čakstiņa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inese Čakstiņa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inese Čakstiņa. The network helps show where Inese Čakstiņa may publish in the future.

Co-authorship network of co-authors of Inese Čakstiņa

This figure shows the co-authorship network connecting the top 25 collaborators of Inese Čakstiņa. A scholar is included among the top collaborators of Inese Čakstiņa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inese Čakstiņa. Inese Čakstiņa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 2
2 19
3 3
4 15
5
Electrically Active and 3D Porous TiO2-x Ceramic Scaffolds for Bone Tissue Regeneration
19
6 24
7 9
8 3
9 8
10 3
11 8
12 4
13 258
14 97
15 1
16 16

About Inese Čakstiņa

Inese Čakstiņa is a scholar working on Genetics, Oral Surgery and Automotive Engineering, having authored 16 papers that have together received 489 indexed citations. Recurring topics across this work include Mesenchymal stem cell research (5 papers), Cancer Cells and Metastasis (3 papers) and RNA Research and Splicing (3 papers). The work is most often cited by research in Genetics (252 citations), Urology (32 citations) and Rehabilitation (34 citations). Inese Čakstiņa has collaborated with scholars based in Latvia, United States and Netherlands. Frequent co-authors include Indriķis Muižnieks, Una Riekstiņa, Jānis Ancāns, Ruta Muceniece, Martin J. Hoogduijn, Vadims Parfejevs, Līga Stīpniece, Nityanand Jain, Jānis Ozoliņš and Jurijs Ozoliņš. Their work appears in journals such as Plant Molecular Biology, Cell Research and Journal of the European Ceramic Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026